Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer

BACKGROUND: The purpose of this study was to perform a systematic review of the interventions for advanced non-small cell lung cancer (NSCLC) including chemotherapy alone and chemotherapy plus COX-2 inhibitors to identify and discuss the cause of any variation across studies and to explore the best...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wei, Liao, Zhi-Min, Fu, Yan, Wu, Ya-Peng, Zhang, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798089/
https://www.ncbi.nlm.nih.gov/pubmed/35116868
http://dx.doi.org/10.21037/tcr.2019.07.06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798089/
https://www.ncbi.nlm.nih.gov/pubmed/35116868
http://dx.doi.org/10.21037/tcr.2019.07.06

Ejemplares similares